Chinmaya Rath
Corporate Officer/Principal bij GLYCOMIMETICS, INC.
Vermogen: 43 679 $ op 31-05-2024
Actieve functies van Chinmaya Rath
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GLYCOMIMETICS, INC. | Corporate Officer/Principal | - | - |
Catena Biosciences, Inc.
 Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Directeur/Bestuurslid | - | - |
| Cellurx | Algemeen Directeur | - | - |
| Oprichter | - | - | |
Social Impact Capital, Inc.
 Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Private Equity Investor | 01-11-2022 | - |
Loopbaan van Chinmaya Rath
Opleiding van Chinmaya Rath
| Warwick Business School | Masters Business Admin |
| Ravenshaw University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
| India | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Catena Biosciences, Inc.
Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Commercial Services |
| Cellurx | |
Social Impact Capital, Inc.
Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
- Beurs
- Insiders
- Chinmaya Rath
- Ervaring
